The platform called TrumpRx won't sell drugs directly, but it is expected to point buyers to drugmakers' own ...

The Trump administration is set to launch TrumpRx, a website to help patients buy prescription drugs directly from manufacturers at discounted rates.

By Atharva Singh and Arasu Kannagi Basil Feb 5 (Reuters) - Drug developer Eikon Therapeutics, headed by Merck veteran Roger ...

Learn about TrumpRx, a new website set to reduce prescription drug prices for millions of Americans starting in 2026.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Health Canada has approved ENFLONSIA® (clesrovimab) for the prevention of respiratory syncytial virus (RSV) ...

BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board.

A new kind of pill sharply reduced cholesterol in people at high risk of heart attacks despite taking statins.

Despite some angst over pricing pressure for GLP-1 drugs, Lilly’s bullish projections surpassed consensus estimates, while ...

Wall Street indexes rise as Palantir reports strong results, boosting optimism for AI investments and corporate earnings this ...

Merck struck two deals in the $10 billion range in 2025, buying Cidara Therapeutics ​and Verona Pharma in order to pick up new drugs before Keytruda, the world's top-selling prescription medicine, ...

Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates, saying the imminent loss of exclusivity on diabetes drug Januvia and other legacy medicines will impact more than ...